|
End-of-day quote
Prague S.E.
09/09/2026
|
5-day change | 1st Jan Change | ||
| 115.50 CZK | 0.00% |
|
-2.12% | -32.06% |
| 06-14 | Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt | CI |
| 06-14 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Pilulka Lékárny
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 4,212 | 1,639 | 665.8 | 291 | 460.1 |
| Change | - | -61.1% | -59.37% | -56.3% | 58.14% |
| Enterprise Value (EV) 1 | 4,141 | 1,618 | 732 | 329.2 | 499.8 |
| Change | - | -60.93% | -54.76% | -55.02% | 51.8% |
| P/E | - | -25.2x | -3.81x | -2.31x | -11.8x |
| PBR | - | 11.7x | 20.3x | -3.1x | -3.44x |
| PEG | - | - | -0x | 0.1x | 0.2x |
| Capitalization / Revenue | 1.77x | 0.67x | 0.31x | 0.22x | 0.53x |
| EV / Revenue | 1.74x | 0.66x | 0.34x | 0.25x | 0.57x |
| EV / EBITDA | 501x | -54.1x | -5.82x | -3.65x | -329x |
| EV / EBIT | -295x | -33.9x | -4.93x | -3x | -30.3x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | -25.76 | -64.63 | -46.46 | -14.36 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 2,380 | 2,447 | 2,132 | 1,304 | 876.4 |
| EBITDA 1 | 8.262 | -29.89 | -125.7 | -90.27 | -1.521 |
| EBIT 1 | -14.05 | -47.74 | -148.6 | -109.9 | -16.48 |
| Net income 1 | -25.5 | -64.94 | -174.9 | -125.7 | -38.87 |
| Net Debt 1 | -71.61 | -20.67 | 66.16 | 38.28 | 39.66 |
| Reference price 2 | 1,685.00 | 650.00 | 246.00 | 107.50 | 170.00 |
| Nbr of stocks (in thousands) | 2,500 | 2,521 | 2,707 | 2,707 | 2,707 |
| Announcement Date | 04/04/23 | 04/04/23 | 29/05/24 | 25/04/25 | 15/06/26 |
1CZK in Million2CZK
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.03M | |
| 16.7x | 0.67x | 10.02x | -.--% | 14.89B | |
| 16.85x | 0.76x | 7.91x | 2.21% | 6.64B | |
| 20.89x | 0.8x | 13.4x | 1.07% | 6.47B | |
| 14.53x | 0.89x | 6.15x | 2.89% | 4.09B | |
| 14.45x | 1.24x | 7.59x | 5.57% | 3.22B | |
| 13.99x | 0.59x | 4.55x | 5.16% | 3.09B | |
| 13.57x | 0.81x | 6.07x | 4.79% | 2.86B | |
| 34.58x | - | - | - | 2.69B | |
| Average | 18.20x | 0.82x | 7.96x | 3.1% | 4.89B | |
| Weighted average by Cap. | 17.67x | 0.77x | 8.95x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PINK Stock
- Valuation Pilulka Lékárny
Select your edition
All financial news and data tailored to specific country editions
